VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at upcoming conferences.
Rodman & Renshaw Annual Global Investment Conference on Monday, September 10, 2012 at 10:25 AM (ET) at the Waldorf-Astoria, New York City.
